dihexa pnb 0408 human trial trials Dihexa (also known as PNB-0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the blood–brain barrier and has shown synaptogenic effects in preclinical Dihexa Peptide - Nationwide Peptides
Description
Avoid tobacco products
limited solubility in water (ionic compound)
It is not approved by the FDA as a dietary supplement ingredient, so it cannot be legally marketed as a supplement, but it is also not a controlled substance
It is not FDA-approved
Fong has authored peer-reviewed research on functional MRI and concussion treatment and has presented at over 60 medical conferences, including the Federal Interagency Conference on TBI and the American Medical Society for Sports Medicine.
